M. Valizadeh Osalo Et Al. , "The prevalence of ADSL (rs3788579) and CYP1A2 (rs17861162) polymorphisms in female breast cancer patients in North-West Iran," Discover Oncology , vol.15, no.1, 2024
Valizadeh Osalo, M. Et Al. 2024. The prevalence of ADSL (rs3788579) and CYP1A2 (rs17861162) polymorphisms in female breast cancer patients in North-West Iran. Discover Oncology , vol.15, no.1 .
Valizadeh Osalo, M., Hosseini, P., Charkhian, H., Soltanzadeh, H., Goharkhany, S., & TUNÇER, Ş. B., (2024). The prevalence of ADSL (rs3788579) and CYP1A2 (rs17861162) polymorphisms in female breast cancer patients in North-West Iran. Discover Oncology , vol.15, no.1.
Valizadeh Osalo, Mohammad Et Al. "The prevalence of ADSL (rs3788579) and CYP1A2 (rs17861162) polymorphisms in female breast cancer patients in North-West Iran," Discover Oncology , vol.15, no.1, 2024
Valizadeh Osalo, Mohammad V. Et Al. "The prevalence of ADSL (rs3788579) and CYP1A2 (rs17861162) polymorphisms in female breast cancer patients in North-West Iran." Discover Oncology , vol.15, no.1, 2024
Valizadeh Osalo, M. Et Al. (2024) . "The prevalence of ADSL (rs3788579) and CYP1A2 (rs17861162) polymorphisms in female breast cancer patients in North-West Iran." Discover Oncology , vol.15, no.1.
@article{article, author={Mohammad Valizadeh Osalo Et Al. }, title={The prevalence of ADSL (rs3788579) and CYP1A2 (rs17861162) polymorphisms in female breast cancer patients in North-West Iran}, journal={Discover Oncology}, year=2024}